Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04990427 · ClinicalTrials.gov registry record · Phase 1
CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)
A Phase 1 study, sponsored by Lisata Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT04990427 is a Phase 1 study that has completed, run by Lisata Therapeutics. The registered enrollment target is 6 participants.
The verdict
NCT04990427, a Phase 1 study, has completed, sponsored by Lisata Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
CLBS201 will evaluate the safety, tolerability, and therapeutic effect in subjects with CKD and T2DM.
Interventions
- DRUG CLBS201
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-01-10 |
| Est. Completion | 2023-01-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04990427
The ClinicalTrials.gov registry entry for NCT04990427 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lisata Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CLBS201 is the first listed.
NCT04990427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04990427 about?
NCT04990427 is a clinical study titled "CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)". CLBS201 will evaluate the safety, tolerability, and therapeutic effect in subjects with CKD and T2DM.
What is the current status of trial NCT04990427?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2022-01-10. Estimated completion is 2023-01-26.
What interventions are being tested in trial NCT04990427?
The interventions under investigation include: CLBS201 (DRUG).
Who is sponsoring clinical trial NCT04990427?
This trial is sponsored by Lisata Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.